Related Experiment Video
Updated: Apr 18, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Recurrent aphthous ulcers among tobacco users- hospital based study
Shamaz Mohamed1, Chandrashekar Janakiram2
1Associate Professor, Department of Public Health Dentistry, Amrita University , Edapally, Cochin, Kerala, India .
Tobacco use is associated with a lower likelihood of developing aphthous ulcers. This study found individuals using tobacco were 59% less likely to experience these oral ulcers compared to non-users.
Area of Science:
- Oral Medicine
- Dental Research
- Public Health
Background:
- The relationship between tobacco consumption and the incidence of aphthous ulcers is not clearly established in existing literature.
- Recurrent aphthous ulcers (RAU) are a common oral condition with multifactorial etiology.
- Understanding potential protective or risk factors, such as tobacco use, is crucial for managing RAU.
Purpose of the Study:
- To investigate the association between various forms of tobacco usage and the occurrence of recurrent aphthous ulcers.
- To determine if tobacco consumption influences the prevalence of aphthous ulceration.
Main Methods:
- A hospital-based case-control study was conducted in a dental teaching hospital in Cochin, India.
- 102 patients diagnosed with aphthous ulceration (cases) and 108 controls without aphthous ulcers were recruited.
- Tobacco usage was assessed through structured interviews.
Main Results:
- An adjusted odds ratio of 0.41 (95% Confidence Interval: 0.19-0.87) was observed for tobacco usage in relation to aphthous ulceration.
- This indicates that tobacco users were 59% less likely to develop aphthous ulcers compared to non-tobacco users.
- The findings suggest a statistically significant inverse relationship between tobacco use and aphthous ulcer occurrence.
Conclusions:
- Tobacco consumers exhibit a lower frequency of aphthous ulceration when compared to individuals who do not use tobacco.
- Tobacco use may have a protective effect against the development of recurrent aphthous ulcers.
More Related Videos
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology